Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [212Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors. | Pharmaceuticals (Basel) | 2023 | 37513897 | PubTator, text mining | PubMed |
| Targeted Alpha-Particle Therapy: A Review of Current Trials. | Int J Mol Sci | 2023 | 37511386 | PubTator, text mining | PubMed |
| Programmed Cell Death Pathways in Cholangiocarcinoma: Opportunities for Targeted Therapy. | Cancers (Basel) | 2023 | 37509299 | PubTator, text mining | PubMed |
| Domperidone Inhibits Clostridium botulinum C2 Toxin and Bordetella pertussis Toxin. | Toxins (Basel) | 2023 | 37505681 | PubTator, text mining | PubMed |
| 1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1. | Mar Drugs | 2023 | 37504943 | PubTator, text mining | PubMed |
| Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by interleukin-6 blockade. | Res Sq | 2023 | 37503252 | PubTator, text mining | PubMed |
| PSMA PET imaging in the diagnosis and management of prostate cancer. | Abdom Radiol (NY) | 2023 | 37493837 | PubTator, text mining | PubMed |
| [Medical Therapies in Functioning Pituitary Neuroendocrine Tumors(PitNETs)]. | No Shinkei Geka | 2023 | 37491068 | PubTator, text mining | PubMed |
| Upregulation of Somatostatin Receptor Type 2 Improves 177Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model. | Mol Cancer Ther | 2023 | 37487000 | PubTator, text mining | PubMed |
| The Influence of Long-Acting Somatostatin Analogs on 68 Ga-DOTATATE Uptake in Patients With Neuroendocrine Tumors. | Clin Nucl Med | 2023 | 37486312 | PubTator, text mining | PubMed |
| Detection of Abdominal Lymph Node Metastasis from Pancreatic Neuroendocrine Tumor by Somatostatin Receptor Scintigraphy: Comparison with Somatostatin Receptor Type 2 Immunostaining. | Case Rep Oncol | 2023 | 37485012 | PubTator, text mining | PubMed |
| Pituitary metastasis of hepatocellular carcinoma as the initial presentations: a case report and review of the literature. | Front Oncol | 2023 | 37483508 | PubTator, text mining | PubMed |
| Deep Learning Approach for the Discovery of Tumor-Targeting Small Organic Ligands from DNA-Encoded Chemical Libraries. | ACS Omega | 2023 | 37483198 | PubTator, text mining | PubMed |
| Neuroendocrine tumors in a patient with multiple endocrine neoplasia type 1 syndrome: A case report and review of the literature. | Medicine (Baltimore) | 2023 | 37478229 | PubTator, text mining | PubMed |
| Case report: Hepatic inflammatory pseudotumor-like follicular dendritic cell sarcoma: a rare case and review of the literature. | Front Med (Lausanne) | 2023 | 37476617 | PubTator, text mining | PubMed |
| 68Ga-SSO-120 PET for Initial Staging of Small Cell Lung Cancer Patients: A Single-Center Retrospective Study. | J Nucl Med | 2023 | 37474272 | PubTator, text mining | PubMed |
| Interaction of Radiopharmaceuticals with Somatostatin Receptor 2 Revealed by Molecular Dynamics Simulations. | J Chem Inf Model | 2023 | 37466559 | PubTator, text mining | PubMed |
| New treatment insights into pancreatic acinar cell carcinoma: case report and literature review. | Front Oncol | 2023 | 37465113 | PubTator, text mining | PubMed |
| DOTATOC PET/CT imaging of a typical carcinoid tumor in a human ex-vivo perfused lung lobe. | Quant Imaging Med Surg | 2023 | 37456303 | PubTator, text mining | PubMed |
| Benefits of combined use of 68-Ga Dotatoc and 5-ALA fluorescence for recurrent atypical skull-base meningioma after previous microsurgery and Gamma Knife radiosurgery: a case report. | J Med Case Rep | 2023 | 37452350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=26